Nebenwirkungen · Cymbalta
Cymbalta 30 mg hard gastro-resistant capsules Cymbalta 60 mg hard gastro-resistant capsules · Abschnitt 4.8 · PDF-Seite 9–10
HOS-113287 · Präparat HOS-093901
9 Very Common Uncommon Rare Very rare Not known common Endocrine disorders Hypo- thyroidism Metabolism and nutrition disorders Decreased Hyperglycaemia Dehydration Appetite (reported Hyponatraemia especially in SIADH6 diabetic patients) Psychiatric disorders Insomnia Suicidal Suicidal Agitation ideation5,7 behaviour5,7 Libido Sleep disorder Mania decreased Bruxism Hallucinations Anxiety Disorientation Aggression and Orgasm Apathy anger4 abnormal Abnormal dreams Nervous system disorders Headache Dizziness Myoclonus Serotonin Somnolence Lethargy Akathisia7 syndrome6 Tremor Nervousness Convulsion1 Paraesthesi Disturbance in Psychomotor a attention restlessness6 Dysgeusia Extra-pyramidal Dyskinesia symptoms6 Restless legs syndrome Poor quality sleep Eye disorders Blurred Mydriasis Glaucoma vision Visual impairment Ear and labyrinth disorders Tinnitus1 Vertigo Ear pain Cardiac disorders Palpitation Tachycardia Stress s Supra- cardiomyopathy ventricular (Takotsubo arrhythmia, cardiomyopathy) mainly atrial fibrillation Vascular disorders Blood Syncope2 Hypertensive pressure Hypertension3,7 crisis3,6 increase 3 Orthostatic Flushing hypotension2 Peripheral coldness
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-07-09T15:40:00Z · SHA-256 a3b2a486f9b4069e76d38032cad9e45c893ee290991d9c0e8b3ea325ef1c101c · Passage 961747abb61dc30625f9d6bc92b74ecba9ba1a0132a10bf2c9ed7bf3f25b4484 · Zeichen 1405–3946 im Abschnitt